← Leaderboards
Douglas Kwon
Massachusetts General Hospital
$11,694,140
Attributed
$24,076,485
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,076,485 · 9
By mechanism
R01$20,343,375 · 7
U01$3,235,187 · 1
K08$497,923 · 1
Top collaborators
- Herbert W Virgin9 shared
- Omer Yilmaz9 shared
- Scott A. Handley6 shared
- Henrik Kloverpris5 shared
- Benjamin D Medoff5 shared
- Ramnik J Xavier5 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Steven Kyle Grinspoon$75,757,679
- Jessica Elizabeth Haberer$14,425,308
- Markella V. Zanni$10,033,281
- Christina Psaros$5,839,764
- Lynn T Matthews$9,738,295
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneMediatingHiv InfectionsCohortCellsChronicAntiretroviral TherapyPathogenesisImmunologyT-LymphocyteTechnologyImmune ActivationSamplingFunctional DisorderMicrobialPhenotypeIntestinesInfectionTissuesCd4 Positive T LymphocytesIntestinal MucosaInflammatoryBacteriaImmune System
Grant awards (38)
Identifying drivers of genital inflammation and HIV acquisition in women living in sub-Saharan Africa$769,000
R01 · FY2025 · AI · contact PI
Immunometabolic regulation of CD8+ T cell mediated intestinal epithelial cell death in people with HIV (PWH)$708,025
R01 · FY2025 · DK · contact PI
Identifying drivers of genital inflammation and HIV acquisition in women living in sub-Saharan Africa$819,227
R01 · FY2024 · AI · contact PI
Immunometabolic regulation of CD8+ T cell mediated intestinal epithelial cell death in people with HIV (PWH)$679,703
R01 · FY2024 · DK · contact PI
Mechanisms of HIV-associated epithelialintestinal stem cell (ISC) dysfunction$675,403
R01 · FY2024 · DK · contact PI
Mechanisms of HIV-associated epithelialintestinal stem cell (ISC) dysfunction$712,540
R01 · FY2023 · DK · contact PI
Immunometabolic regulation of CD8+ T cell mediated intestinal epithelial cell death in people with HIV (PWH)$708,025
R01 · FY2023 · DK · contact PI
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity$846,940
R01 · FY2022 · DK · contact PI
Mechanisms of HIV-associated epithelialintestinal stem cell (ISC) dysfunction$711,945
R01 · FY2022 · DK · contact PI
Immunometabolic regulation of CD8+ T cell mediated intestinal epithelial cell death in people with HIV (PWH)$708,025
R01 · FY2022 · DK · contact PI
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity$846,940
R01 · FY2021 · DK · contact PI
Mechanisms of HIV-associated epithelial intestinal stem cell (ISC) dysfunction$711,945
R01 · FY2021 · DK · contact PI
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity$792,154
R01 · FY2020 · DK · contact PI
Mechanisms of HIV-associated epithelial intestinal stem cell (ISC) dysfunction$746,550
R01 · FY2020 · DK · contact PI
The enteric microbiome in HIV-associated chronic immune activation and cardiovascular disease$507,964
R01 · FY2020 · HL · contact PI
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity$804,896
R01 · FY2019 · DK · contact PI
The enteric microbiome in HIV-associated chronic immune activation and cardiovascular disease$509,003
R01 · FY2019 · HL · contact PI
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity$816,908
R01 · FY2018 · DK · contact PI
The enteric microbiome in treated and progressive HIV infection$723,582
R01 · FY2018 · DK · contact PI
The enteric microbiome in HIV-associated chronic immune activation and cardiovascular disease$510,008
R01 · FY2018 · HL · contact PI
The enteric microbiome in treated and progressive HIV infection$723,582
R01 · FY2017 · DK · contact PI
HIV and COPD:Immune mediated mechanisms$655,958
U01 · FY2017 · HL
Inflammation and the vaginal metagenome in HIV acquisition$612,193
R01 · FY2017 · AI · contact PI
The enteric microbiome in HIV-associated chronic immune activation and cardiovascular disease$528,734
R01 · FY2017 · HL · contact PI
The enteric microbiome in treated and progressive HIV infection$723,583
R01 · FY2016 · DK · contact PI
HIV and COPD:Immune mediated mechanisms$655,958
U01 · FY2016 · HL
Inflammation and the vaginal metagenome in HIV acquisition$612,771
R01 · FY2016 · AI · contact PI
The enteric microbiome in treated and progressive HIV infection$705,157
R01 · FY2015 · DK · contact PI
HIV and COPD:Immune mediated mechanisms$655,958
U01 · FY2015 · HL
Inflammation and the vaginal metagenome in HIV acquisition$633,994
R01 · FY2015 · AI · contact PI
The enteric microbiome in treated and progressive HIV infection$804,179
R01 · FY2014 · DK · contact PI
Inflammation and the vaginal metagenome in HIV acquisition$690,399
R01 · FY2014 · AI · contact PI
HIV and COPD:Immune mediated mechanisms$642,841
U01 · FY2014 · HL
HIV and COPD:Immune mediated mechanisms$624,472
U01 · FY2013 · HL
Gut mucosal immunity to HIV-1 in controlled and progressive infection$126,702
K08 · FY2012 · AI · contact PI
Gut mucosal immunity to HIV-1 in controlled and progressive infection$126,752
K08 · FY2011 · AI · contact PI
Gut mucosal immunity to HIV-1 in controlled and progressive infection$123,711
K08 · FY2010 · AI · contact PI
Gut mucosal immunity to HIV-1 in controlled and progressive infection$120,758
K08 · FY2009 · AI · contact PI